reviewOncogeneAug 1, 2009BRONZE OA

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

AFAdi F. Gazdar

Southwestern Medical Center · The University of Texas Southwestern Medical Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

985
total citations
FWCI
39.19
Percentile
100%
References
54
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Gefitinib
  • Erlotinib
  • T790M
  • Biology
  • Cancer research
  • Tyrosine kinase
  • Afatinib
  • Epidermal growth factor receptor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding